FMP
Invesco Dynamic Biotechnology & Genome ETF
PBE
AMEX
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
61.14 USD
-0.0071 (-0.01161%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
CIK
0001209466
ISIN
US46137V7872
CUSIP
46137V787
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Jun 23, 2005
Summary
ISIN
US46137V7872
Exchange
AMEX
Beta
0.82
Market Cap
278.19M
52-Week
52.47-67.76
Volume Avg.
15.4k
Price
61.14
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Historical Prices
We are unable to load the chart at this time.
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PBE News
It looks like there's no news available.
